Discounted Cash Flow Rating
Buy
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Sell
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Buy
A
Champions Oncology, Inc. (CSBR)
Biological Products, (no Disgnostic Substances)
https://www.championsoncology.com
Champions Oncology Inc is a us-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies.
855 N. WOLFE STREET, SUITE 619
BALTIMORE, MD
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
02/02/2007
Market Cap
60,084,596
Shares Outstanding
13,590,000
Weighted SO
13,593,767
Total Employees
N/A
Upcoming Earnings
07/18/2024
Beta
0.4930
Last Div
0.0000
Range
4.42-7.13
Chg
-0.0800
Avg Vol
6709
Mkt Cap
60084596
Exch
NASDAQ
Country
US
Phone
201 808 8400
DCF Diff
9.1284
DCF
-4.5000
Div Yield
0.0000
P/S
1.1980
EV Multiple
-15.1947
P/FV
-31.5735
Div Yield %
0.0000
P/E
-8.2579
PEG
-0.6578
Payout
0.0000
Current Ratio
0.6332
Quick Ratio
0.6332
Cash Ratio
0.1215
DSO
69.3263
DIO
0.0000
Op Cycle
69.3263
DPO
72.0044
CCC
-2.6781
Gross Margin
0.4138
Op Margin
-0.1380
Pretax Margin
-0.1457
Net Margin
-0.1451
Eff Tax Rate
0.0044
ROA
-0.2784
ROE
14.8112
ROCE
-1.5073
NI/EBT
0.9956
EBT/EBIT
1.0561
EBIT/Rev
-0.1380
Debt Ratio
0.2843
D/E
-3.9044
LT Debt/Cap
1.4542
Total Debt/Cap
1.3443
Int Coverage
0.0000
CF/Debt
-0.8260
Equity Multi
-13.7320
Rec Turnover
5.2650
Pay Turnover
5.0691
Inv Turnover
999999.9999
FA Turnover
4.1889
Asset Turnover
1.9193
OCF/Share
-0.4515
FCF/Share
-0.5130
Cash/Share
0.1926
OCF/Sales
-0.1224
FCF/OCF
1.1362
CF Coverage
-0.8260
ST Coverage
-4.5901
CapEx Coverage
-7.3409
Div&CapEx Cov
-7.3409
P/BV
-31.5735
P/B
-31.5735
P/S
1.1980
P/E
-8.2579
P/FCF
-8.6167
P/OCF
-9.7905
P/CF
-9.7905
PEG
-0.6578
P/S
1.1980
EV Multiple
-15.1947
P/FV
-31.5735
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
14.94K Shares Bought (99.99 %)
0.00 Shares Sold (0.01%)
6 - 9 Months
471.34K Shares Bought (97.01 %)
14.55K Shares Sold (2.99%)
9 - 12 Months
35.83K Shares Bought (100.00 %)
0.00 Shares Sold (0.00 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 4.92M | ▲ 7.72M | ▲ 8.75M | ▲ 10.57M | ▲ 12.88M | ▲ 13.07M | ▼ 12.02M |
Cost Of Revenue | 2.82M | ▲ 4.30M | ▲ 4.92M | ▲ 5.65M | ▲ 6.22M | ▲ 7.34M | ▲ 7.85M |
Gross Profit | 2.10M | ▲ 3.42M | ▲ 3.83M | ▲ 4.91M | ▲ 6.66M | ▼ 5.73M | ▼ 4.17M |
Gross Profit Ratio | 0.43 | ▲ 0.44 | ▼ 0.44 | ▲ 0.46 | ▲ 0.52 | ▼ 0.44 | ▼ 0.35 |
Research And Development Expenses | 1.09M | ▲ 1.25M | ▲ 1.82M | ▲ 2.07M | ▲ 2.59M | ▲ 2.85M | ▼ 2.19M |
General And Administrative Expenses | 888.00K | ▲ 1.37M | ▲ 2.50M | ▼ 1.83M | ▲ 2.76M | ▼ 2.75M | ▲ 2.76M |
Selling And Marketing Expenses | 715.00K | ▲ 918.00K | ▲ 1.09M | ▲ 1.47M | ▲ 1.62M | ▲ 1.85M | ▼ 1.80M |
Selling General And Administrative Expenses | 1.60M | ▲ 2.29M | ▲ 3.58M | ▼ 3.30M | ▲ 4.38M | ▲ 4.60M | ▼ 4.56M |
Other Expenses | -24.00K | ▼ -33.00K | ▼ -44.00K | ▲ 7.00K | ▼ -35.00K | ▲ -20.00K | ▲ 58.00K |
Operating Expenses | 2.70M | ▲ 3.53M | ▲ 5.40M | ▼ 5.37M | ▲ 6.97M | ▲ 7.45M | ▼ 6.75M |
Cost And Expenses | 5.52M | ▲ 7.84M | ▲ 10.33M | ▲ 11.02M | ▲ 13.19M | ▲ 14.79M | ▼ 14.60M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -533.00K | ▲ 584.00K | ▼ 0.00 |
Depreciation And Amortization | 107.00K | ▲ 173.00K | ▲ 246.00K | ▲ 303.00K | ▲ 568.00K | ▲ 1.39M | ▼ 1.26M |
Ebitda | -487.00K | ▲ -117.00K | ▼ -995.00K | ▲ -153.00K | ▼ -311.00K | ▼ -324.00K | ▼ -1.31M |
Ebitda Ratio | -0.10 | ▲ -0.02 | ▼ -0.11 | ▲ -0.01 | ▼ -0.02 | ▼ -0.02 | ▼ -0.11 |
Operating Income | -594.00K | ▲ -117.00K | ▼ -1.91M | ▲ -456.00K | ▲ -311.00K | ▼ -1.71M | ▼ -2.58M |
Operating Income Ratio | -0.12 | ▲ -0.02 | ▼ -0.22 | ▲ -0.04 | ▲ -0.02 | ▼ -0.13 | ▼ -0.21 |
Total Other Income Expenses Net | -24.00K | ▼ -33.00K | ▼ -379.00K | ▲ 7.00K | ▼ -35.00K | ▼ -827.00K | ▲ 58.00K |
Income Before Tax | -618.00K | ▲ -150.00K | ▼ -1.95M | ▲ -449.00K | ▲ -346.00K | ▼ -2.54M | ▲ -2.52M |
Income Before Tax Ratio | -0.13 | ▲ -0.02 | ▼ -0.22 | ▲ -0.04 | ▲ -0.03 | ▼ -0.19 | ▼ -0.21 |
Income Tax Expense | 44.00K | ▲ 102.00K | ▼ 93.00K | ▼ 32.00K | ▼ -2.00K | ▲ 20.00K | ▼ 11.00K |
Net Income | -662.00K | ▲ -252.00K | ▼ -2.05M | ▲ -481.00K | ▲ -344.00K | ▼ -2.56M | ▲ -2.53M |
Net Income Ratio | -0.13 | ▲ -0.03 | ▼ -0.23 | ▲ -0.05 | ▲ -0.03 | ▼ -0.20 | ▼ -0.21 |
Eps | -0.06 | ▲ -0.02 | ▼ -0.17 | ▲ -0.04 | ▲ -0.03 | ▼ -0.19 | -0.19 |
Eps Diluted | -0.06 | ▲ -0.02 | ▼ -0.17 | ▲ -0.04 | ▲ -0.03 | ▼ -0.19 | -0.19 |
Weighted Average Shs Out | 11.00M | ▲ 11.62M | ▲ 11.84M | ▲ 13.40M | ▼ 13.28M | ▲ 13.54M | ▲ 13.59M |
Weighted Average Shs Out Dil | 11.00M | ▲ 11.62M | ▲ 12.39M | ▲ 13.40M | ▲ 13.51M | ▲ 13.54M | ▲ 13.59M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 856.00K | ▲ 3.24M | ▲ 8.34M | ▼ 4.69M | ▲ 9.01M | ▲ 10.12M | ▼ 4.47M |
Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 856.00K | ▲ 3.24M | ▲ 8.34M | ▼ 4.69M | ▲ 9.01M | ▲ 10.12M | ▼ 4.47M |
Net Receivables | 3.92M | ▲ 4.38M | ▲ 4.77M | ▲ 6.99M | ▲ 9.51M | ▼ 8.01M | ▼ 7.90M |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Other Current Assets | 287.00K | ▲ 308.00K | ▲ 385.00K | ▲ 957.00K | ▲ 1.14M | ▲ 1.33M | ▼ 835.00K |
Total Current Assets | 5.06M | ▲ 7.92M | ▲ 13.50M | ▼ 12.63M | ▲ 19.66M | ▼ 19.46M | ▼ 13.20M |
Property Plant Equipment Net | 2.08M | ▲ 2.55M | ▲ 6.79M | ▲ 14.61M | ▲ 15.36M | ▼ 14.50M | ▼ 13.07M |
Goodwill | 669.00K | 669.00K | ▼ 335.00K | 335.00K | 335.00K | 335.00K | 335.00K |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 669.00K | 669.00K | ▼ 335.00K | 335.00K | 335.00K | 335.00K | 335.00K |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 266.00K | ▼ 128.00K | 128.00K | ▼ 15.00K | 15.00K | 15.00K | ▲ 185.00K |
Total Non Current Assets | 3.02M | ▲ 3.34M | ▲ 7.25M | ▲ 14.96M | ▲ 15.71M | ▼ 14.85M | ▼ 13.59M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Total Assets | 8.08M | ▲ 11.27M | ▲ 20.75M | ▲ 27.59M | ▲ 35.38M | ▼ 34.31M | ▼ 26.79M |
Account Payables | 2.15M | ▲ 2.81M | ▲ 3.14M | ▼ 1.89M | ▲ 2.87M | ▲ 5.33M | ▼ 4.76M |
Short Term Debt | 29.00K | ▼ 16.00K | ▲ 628.00K | ▲ 818.00K | ▲ 1.05M | ▲ 1.21M | ▲ 1.31M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 4.70M | ▼ 4.02M | ▲ 5.82M | ▲ 6.26M | ▲ 11.07M | ▲ 12.78M | ▲ 13.33M |
Other Current Liabilities | 595.00K | ▲ 1.18M | ▲ 2.50M | ▼ 2.23M | ▲ 2.49M | ▼ 2.42M | ▲ 2.58M |
Total Current Liabilities | 7.48M | ▲ 8.03M | ▲ 12.09M | ▼ 11.20M | ▲ 17.48M | ▲ 21.73M | ▲ 21.97M |
Long Term Debt | 0.00 | 0.00 | ▲ 3.17M | ▲ 8.78M | ▼ 8.41M | ▼ 7.39M | ▼ 6.44M |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 621.00K | ▲ 1.00M | ▼ 178.00K | ▲ 181.00K | ▲ 391.00K | ▲ 551.00K | ▼ 439.00K |
Total Non Current Liabilities | 621.00K | ▲ 1.00M | ▲ 3.35M | ▲ 8.96M | ▼ 8.80M | ▼ 7.94M | ▼ 6.88M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Capital Lease Obligations | 0.00 | ▲ 16.00K | ▲ 3.80M | ▲ 9.60M | ▼ 9.47M | ▼ 8.60M | ▼ 6.44M |
Total Liabilities | 8.10M | ▲ 9.03M | ▲ 15.43M | ▲ 20.16M | ▲ 26.28M | ▲ 29.68M | ▼ 28.85M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 11.00K | ▲ 12.00K | ▲ 13.00K | 13.00K | ▲ 14.00K | 14.00K | 14.00K |
Retained Earnings | -70.83M | ▲ -70.70M | ▼ -72.67M | ▲ -72.53M | ▲ -71.98M | ▼ -77.32M | ▼ -84.48M |
Accumulated Other Comprehensive Income Loss | -1.47M | ▼ -2.07M | ▼ -2.77M | ▼ -3.96M | ▲ 0.00 | 0.00 | 0.00 |
Other Total Stockholders Equity | 72.29M | ▲ 75.00M | ▲ 80.75M | ▲ 83.90M | ▼ 81.06M | ▲ 81.94M | ▲ 82.41M |
Total Stockholders Equity | -25.00K | ▲ 2.24M | ▲ 5.32M | ▲ 7.43M | ▲ 9.10M | ▼ 4.64M | ▼ -2.06M |
Total Equity | -25.00K | ▲ 2.24M | ▲ 5.32M | ▲ 7.43M | ▲ 9.10M | ▼ 4.64M | ▼ -2.06M |
Total Liabilities And Stockholders Equity | 8.08M | ▲ 11.27M | ▲ 20.75M | ▲ 27.59M | ▲ 35.38M | ▼ 34.31M | ▼ 26.79M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 8.08M | ▲ 11.27M | ▲ 20.75M | ▲ 27.59M | ▲ 35.38M | ▼ 34.31M | ▼ 26.79M |
Total Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt | 40.00K | ▼ 16.00K | ▲ 3.80M | ▲ 9.60M | ▼ 9.47M | ▼ 8.60M | ▼ 7.74M |
Net Debt | -816.00K | ▼ -3.22M | ▼ -4.54M | ▲ 4.91M | ▼ 459.00K | ▼ -1.52M | ▲ 3.27M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -661.00K | ▲ -253.00K | ▼ -2.05M | ▲ -482.00K | ▲ -344.00K | ▼ -2.56M | ▲ -2.53M |
Depreciation And Amortization | 107.00K | ▲ 173.00K | ▲ 246.00K | ▲ 303.00K | ▲ 568.00K | ▲ 583.00K | ▲ 1.26M |
Deferred Income Tax | -44.00K | ▲ 18.00K | ▲ 394.00K | ▼ 0.00 | 0.00 | ▲ 919.00K | ▼ -1.34M |
Stock Based Compensation | 156.00K | ▼ 138.00K | ▲ 163.00K | ▼ 161.00K | ▲ 188.00K | ▲ 208.00K | ▲ 379.00K |
Change In Working Capital | -25.00K | ▲ 60.00K | ▲ 3.69M | ▼ -2.13M | ▲ -42.00K | ▲ 7.00K | ▲ 375.00K |
Accounts Receivables | -931.00K | ▲ -476.00K | ▲ -336.00K | ▼ -864.00K | ▼ -1.13M | ▲ -69.00K | ▼ -250.00K |
Inventory | -124.00K | ▲ 538.00K | ▲ 1.55M | ▼ -1.06M | ▲ 0.00 | ▼ -3.77M | ▲ 0.00 |
Accounts Payables | 177.00K | ▲ 699.00K | ▲ 1.25M | ▼ 149.00K | ▼ -798.00K | ▲ 1.04M | ▼ 222.00K |
Other Working Capital | 853.00K | ▼ -701.00K | ▲ 1.23M | ▼ -360.00K | ▲ 1.88M | ▲ 2.81M | ▼ 403.00K |
Other Non Cash Items | 476.00K | ▼ 116.00K | ▼ 104.00K | ▲ 172.00K | ▲ 426.00K | ▼ 135.00K | ▲ 935.00K |
Net Cash Provided By Operating Activities | 9.00K | ▲ 252.00K | ▲ 2.55M | ▼ -1.98M | ▲ 796.00K | ▼ -709.00K | ▼ -919.00K |
Investments In Property Plant And Equipment | -212.00K | ▲ -141.00K | ▼ -1.53M | ▲ -854.00K | ▲ -506.00K | ▼ -760.00K | ▲ -126.00K |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 3.00K | ▼ 0.00 | 0.00 | ▲ 20.00K | ▼ 0.00 | 0.00 | 0.00 |
Net Cash Used For Investing Activities | -209.00K | ▲ -141.00K | ▼ -1.53M | ▲ -834.00K | ▲ -506.00K | ▼ -760.00K | ▲ -126.00K |
Debt Repayment | -6.00K | ▼ -209.00K | ▲ -16.00K | ▲ -1.00K | ▲ 0.00 | 0.00 | 0.00 |
Common Stock Issued | 30.00K | ▼ 6.00K | ▼ 0.00 | 0.00 | ▲ 16.00K | ▼ -1.00K | ▲ 0.00 |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -74.00K | ▲ 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -30.00K | ▲ 19.00K | ▲ 4.06M | ▼ 73.00K | ▼ 16.00K | ▼ -75.00K | ▲ 0.00 |
Net Cash Used Provided By Financing Activities | -6.00K | ▼ -184.00K | ▲ 4.04M | ▼ 72.00K | ▼ 16.00K | ▼ -75.00K | ▲ 0.00 |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 17.00K | ▼ 0.00 |
Net Change In Cash | -206.00K | ▲ -73.00K | ▲ 5.06M | ▼ -2.74M | ▲ 306.00K | ▼ -1.54M | ▲ -1.05M |
Cash At End Of Period | 856.00K | ▲ 3.24M | ▲ 8.34M | ▼ 4.69M | ▲ 9.01M | ▲ 10.10M | ▼ 4.47M |
Cash At Beginning Of Period | 1.06M | ▲ 3.31M | ▼ 3.28M | ▲ 7.43M | ▲ 8.70M | ▲ 11.65M | ▼ 5.51M |
Operating Cash Flow | 9.00K | ▲ 252.00K | ▲ 2.55M | ▼ -1.98M | ▲ 796.00K | ▼ -709.00K | ▼ -919.00K |
Capital Expenditure | -212.00K | ▲ -141.00K | ▼ -1.53M | ▲ -854.00K | ▲ -506.00K | ▼ -760.00K | ▲ -126.00K |
Free Cash Flow | -203.00K | ▲ 111.00K | ▲ 1.02M | ▼ -2.83M | ▲ 290.00K | ▼ -1.47M | ▲ -1.05M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)